review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1152/PHYSREV.2001.81.3.999 |
P698 | PubMed publication ID | 11427690 |
P2093 | author name string | Berk BC | |
P2860 | cites work | Cell transformation by the superoxide-generating oxidase Mox1 | Q22010372 |
P433 | issue | 3 | |
P304 | page(s) | 999-1030 | |
P577 | publication date | 2001-07-01 | |
P1433 | published in | Physiological Reviews | Q1091827 |
P1476 | title | Vascular smooth muscle growth: autocrine growth mechanisms | |
P478 | volume | 81 |
Q54612212 | 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. |
Q24338328 | 12S-Lipoxygenase is necessary for human vascular smooth muscle cell survival |
Q92506834 | A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis |
Q50421787 | Abrogation of TGF-beta signalling in TAGLN expressing cells recapitulates Pentalogy of Cantrell in the mouse. |
Q54765190 | Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. |
Q35033814 | Activation of heterotrimeric G proteins by Smoothened |
Q33650943 | Activation of phospholipase C gamma 1 protects renal arteriolar VSMCs from H2O2-induced cell death |
Q34002877 | Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells |
Q42714688 | Affinity peptides protect transforming growth factor beta during encapsulation in poly(ethylene glycol) hydrogels. |
Q36494654 | Altered hemodynamics, endothelial function, and protein expression occur with aortic coarctation and persist after repair |
Q38680594 | An overview of potential molecular mechanisms involved in VSMC phenotypic modulation |
Q35849415 | Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle. |
Q37508320 | Arsenic alters vascular smooth muscle cell focal adhesion complexes leading to activation of FAK-src mediated pathways |
Q36720080 | Axl-dependent signalling: a clinical update |
Q37856434 | Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting. |
Q24337549 | Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis |
Q58796774 | Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis |
Q42416262 | Ca2+, calmodulin, and cyclins in vascular smooth muscle cell cycle |
Q44285686 | Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury |
Q37215257 | Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism |
Q24298303 | Characterization of Mesenchyme Homeobox 2 (MEOX2) transcription factor binding to RING finger protein 10 |
Q37323727 | Characterization of primary cilia in human airway smooth muscle cells |
Q54688073 | Conditional inactivation of TGF-β type II receptor in smooth muscle cells and epicardium causes lethal aortic and cardiac defects. |
Q37801787 | Cyclophilin A - Promising New Target in Cardiovascular Therapy - |
Q28396302 | Cytochrome P450 eicosanoids and cerebral vascular function |
Q49787455 | DAPK and CIP2A are involved in GAS6/AXL-mediated Schwann cell proliferation in a rat model of bilateral cavernous nerve injury |
Q46915161 | Decreased function of voltage-gated potassium channels contributes to augmented myogenic tone of uterine arteries in late pregnancy. |
Q64018870 | Do two mutually exclusive gene modules define the phenotypic diversity of mammalian smooth muscle? |
Q38177120 | Dual roles of vascular-derived reactive oxygen species--with a special reference to hydrogen peroxide and cyclophilin A. |
Q42521607 | Early changes in proteoglycans production by resistance arteries smooth muscle cells of hypertensive rats |
Q53261301 | Effects of streptozotocin and unilateral nephrectomy on L-type Ca²⁺ channels and membrane capacitance in arteriolar smooth muscle cells. |
Q42478836 | Effects of tautomycetin on proliferation and fibronectin secretion in vascular smooth muscle cells and glomerular mesangial cells. |
Q28510995 | Elastin induces myofibrillogenesis via a specific domain, VGVAPG |
Q33925149 | Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling |
Q41906789 | Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2. |
Q34312310 | Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR |
Q24298549 | Epiregulin as a major autocrine/paracrine factor released from ERK- and p38MAPK-activated vascular smooth muscle cells |
Q28053441 | Fibronectin is an important regulator of flow-induced vascular remodeling |
Q40010300 | GIT1 mediates HDAC5 activation by angiotensin II in vascular smooth muscle cells |
Q36317485 | Galectin-3 mediates the effect of PDGF on pulmonary arterial hypertension |
Q38698722 | Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells |
Q36342556 | Growth factors in lung development. |
Q41864365 | Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery |
Q31126617 | High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity |
Q34314221 | Histamine-mediated increases in cytosolic [Ca2+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells |
Q38938540 | Increase in neuropilin-1 on the surface of growth cones and putative raft domains in neuronal NG108-15 cells co-cultured with vascular smooth muscle SM-3 cells |
Q37486289 | Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium |
Q34549788 | Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation |
Q37395007 | Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway |
Q46560748 | KLF5 and hhLIM cooperatively promote proliferation of vascular smooth muscle cells |
Q28213257 | Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling |
Q50078162 | LIM and cysteine-rich domains 1 is required for thrombin-induced smooth muscle cell proliferation and promotes atherogenesis |
Q28573249 | Label-free quantitative analysis of one-dimensional PAGE LC/MS/MS proteome: application on angiotensin II-stimulated smooth muscle cells secretome |
Q28512646 | Lack of bcr and abr promotes hypoxia-induced pulmonary hypertension in mice |
Q37382272 | Local uteroplacental influences are responsible for the induction of uterine artery myogenic tone during rat pregnancy |
Q36162737 | Luteolin Ameliorates Hypertensive Vascular Remodeling through Inhibiting the Proliferation and Migration of Vascular Smooth Muscle Cells |
Q33750575 | Mechanical stretch and intimal hyperplasia: the missing link? |
Q38772293 | Mechanism by which nuclear factor-kappa beta (NF-kB) regulates ovine fetal pulmonary vascular smooth muscle cell proliferation |
Q38224470 | Metalloproteinases in hypertension and cardiac disease: differential expression and mutual regulation |
Q64083270 | Metformin Inhibits the Expression of Biomarkers of Fibrosis of EPCs In Vitro |
Q42970195 | Mitogenic factors promoting intestinal smooth muscle cell proliferation |
Q37057306 | Novel role of cortactin in G protein-coupled receptor agonist-induced nuclear export and degradation of p21Cip1. |
Q36720089 | Novel tyrosine kinase signaling pathways: implications in vascular remodeling |
Q37048514 | Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall re |
Q44631219 | Oxidant-induced pHi/Ca2+ changes in rat aortic smooth muscle cells. The role of atrial natriuretic peptide |
Q33818137 | Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A |
Q37070994 | PDGF induces SphK1 expression via Egr-1 to promote pulmonary artery smooth muscle cell proliferation |
Q45208517 | PGC-1alpha attenuates neointimal formation via inhibition of vascular smooth muscle cell migration in the injured rat carotid artery |
Q45241916 | PKC-delta-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle |
Q36368850 | PLCβ3 mediates cortactin interaction with WAVE2 in MCP1-induced actin polymerization and cell migration |
Q39246076 | Patterns of kinase activation induced by injury in the murine femoral artery |
Q35005859 | Pipoxolan ameliorates cerebral ischemia via inhibition of neuronal apoptosis and intimal hyperplasia through attenuation of VSMC migration and modulation of matrix metalloproteinase-2/9 and Ras/MEK/ERK signaling pathways |
Q45996166 | Platelet-activating factor stimulates ovine foetal pulmonary vascular smooth muscle cell proliferation: role of nuclear factor-kappa B and cyclin-dependent kinases. |
Q80093337 | Preparation of primary cultured mesenteric artery smooth muscle cells for fluorescent imaging and physiological studies |
Q36332889 | Protein kinase N1 is a novel substrate of NFATc1-mediated cyclin D1-CDK6 activity and modulates vascular smooth muscle cell division and migration leading to inward blood vessel wall remodeling |
Q33355857 | R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome |
Q37081874 | Redox compartmentalization in eukaryotic cells |
Q38092684 | Region-specific vascular remodeling and its prevention by artificial gravity in weightless environment |
Q35095426 | Regulation of smooth muscle phenotype |
Q38583217 | Regulator of calcineurin 1 mediates pathological vascular wall remodeling |
Q40419294 | Requirement of an intermediate gene expression for biphasic ERK1/2 activation in thrombin-stimulated vascular smooth muscle cells |
Q37881804 | Rho-kinase: important new therapeutic target in cardiovascular diseases |
Q37209956 | RhoA-Rho kinase and platelet-activating factor stimulation of ovine foetal pulmonary vascular smooth muscle cell proliferation |
Q36068101 | Role of PKCδ in Enhanced Expression of Gqα/PLCβ1 Proteins and VSMC Hypertrophy in Spontaneously Hypertensive Rats |
Q35582293 | SOXF: redox mediators of vascular smooth muscle cell growth |
Q83653884 | Salvianolic acid A inhibits PDGF-BB induced vascular smooth muscle cell migration and proliferation while does not constrain endothelial cell proliferation and nitric oxide biosynthesis |
Q38272996 | Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system |
Q47689003 | Simvastatin attenuated rat thoracic aorta remodeling by decreasing ROCK2‑mediated CyPA secretion and CD147‑ERK1/2‑cyclin pathway |
Q34492807 | Small artery remodeling in hypertension. |
Q37021191 | Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). |
Q38112038 | Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension |
Q38170045 | Smooth muscle cell phenotypic switching in stroke. |
Q34960327 | Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation |
Q40730138 | Stimulation of DNA synthesis, activation of mitogen-activated protein kinase ERK2 and nuclear accumulation of c-fos in human aortic smooth muscle cells by ketamine |
Q92759498 | The 9p21.3 risk locus for coronary artery disease: A 10-year search for its mechanism |
Q46236716 | The Role of Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Lung Architecture Remodeling |
Q36990311 | The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition |
Q46511471 | The proteasome inhibitor bortezomib inhibits intimal hyperplasia of autologous vein grafting in rat model |
Q38365018 | The regulator of calcineurin (RCAN1) an important factor involved in atherosclerosis and cardiovascular diseases development |
Q35087027 | The role of angiotensin II in regulating vascular structural and functional changes in hypertension |
Q43276027 | The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells |
Q33233774 | Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis |
Q39618425 | Transfection of hairpin small interfering RNA expression vector targeting rat nuclear factor (NF) (κB) inhibits rat cell proliferation induced by NF-κB signal pathway activation |
Q46755210 | Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells |
Q42151020 | Translocon closure to Ca2+ leak in proliferating vascular smooth muscle cells |
Q47988717 | Vascular contractile reactivity in hypotension due to reduced renal reabsorption of Na+ and restricted dietary Na. |
Q34432730 | Vascular smooth muscle phenotypic diversity and function |
Q37997898 | Vein graft failure: current clinical practice and potential for gene therapeutics |
Q42674798 | mRNA differential display identification of vascular smooth muscle early response genes regulated by PDGF. |
Q50920114 | p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine-induced vascular smooth muscle cell migration and proliferation. |
Search more.